stars 1 stars 2 stars 3

Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed us to advance from target discovery in our laboratory to treating patients in clinical trials at an accelerated pace. We are investigating many of the largest and most lethal cancers through our proprietary platforms that identify cancer stem cells, discover novel targets, engineer and manufacture antibodies and antibody drug conjugates. Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Stemcentrx has assembled a talented and motivated team committed to this mission. We are recruiting people with world-class expertise in their practice, versatility, high energy and an entrepreneurial spirit. Our state-of-the-art laboratories and manufacturing facilities are located in South San Francisco, California. We have a driven, ambitious, focused, hard-working, apolitical, fun, and collaborative culture that is more typical of Silicon Valley startups than large pharmaceutical companies. Our employees are compensated with salary, benefits and stock options.

Website http://www.stemcentrx.com/
Revenue $17.8 million
Employees 6 (4 on RocketReach)
Founded 2008
Address 450 East Jamie Court, South San Francisco, California 94080, US
Phone +1 650-491-0120
Fax (650) 491-0116
Technologies
Industry Biotechnology, Biotechnology Research, Pharmaceuticals, Alternative Medicine, Solid Tumor Cancer Stem Cell Discovery & Targeted Therapeutics, Healthcare, Health Care, Drug Manufacturing & Research, Science and Engineering, Health Diagnostics, Pharmaceutical, Therapeutics
Web Rank 19 Million
Keywords Cancer Treatment, Biotechnology, Oncology, Pharmaceutical, Drug Development, Clinical Trials, Immunotherapy, Precision Medicine, Biopharma, Pharmaceutical Research, Biologics, Target Discovery, Clinical Research, Research, Gmp Manufacturing, Life Sciences, Therapeutics, Healthcare, Medicine
Competitors Roche, Novartis, Bristol Myers Squibb, Genentech, Amgen, Gilead Sciences, Incyte, Receptos, a wholly-owned subsidiary of Celgene, Lengo Therapeutics, Aprea Therapeutics, Inc. +38 more (view full list)
SIC SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies
NAICS NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies

Stemcentrx, Inc. Questions

The Stemcentrx, Inc. annual revenue was $17.8 million in 2026.

Chris Dayton is the Senior Director of Intellectual Property of Stemcentrx, Inc..

4 people are employed at Stemcentrx, Inc..

Stemcentrx, Inc. is based in South San Francisco, California.

The NAICS codes for Stemcentrx, Inc. are [32, 3254, 32541, 325].

The SIC codes for Stemcentrx, Inc. are [2834, 28, 283].

Top Stemcentrx, Inc. Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users